Results 121 to 130 of about 29,028 (227)

Osmoregulatory contributions of the corticotropin-releasing factor system in the intestine of Atlantic salmon. [PDF]

J Exp Biol
Culbert BM, McCormick SD, Bernier NJ.
europepmc   +1 more source

Androgen Regulation of Corticotropin Releasing Factor Receptor 1 in the Mouse Brain. [PDF]

Neuroscience, 2022
Rybka KA, Sturm KL, De Guzman RM, Bah S, Jacobskind JS, Rosinger ZJ, Taroc EZM, Forni PE, Zuloaga DG.   +8 more
europepmc   +1 more source

Rolf Christian Gaillard (1944–2011): A builder of modern European endocrinology and neuroendocrinology

Journal of Neuroendocrinology, Volume 38, Issue 8, August 2026.
Abstract Rolf Christian Gaillard was a Swiss physician, scientist, and academic leader whose career contributed significantly to the development of modern European endocrinology and neuroendocrinology. Among his most remarkable qualities was an exceptional talent for organisation and institution‐building.
Philippe Chanson, Eduardo Spinedi, François Pralong   +2 more
wiley   +1 more source

Mast cell corticotropin-releasing factor receptor 1 contributes to pancreatic cancer pain via mitogen-activated protein kinase/sphingosine kinases type 1 signaling. [PDF]

Pain
Zhang Y, Wei K, Tao K, Ma M, Lu Z.
europepmc   +1 more source

Stress-induced bladder hypersensitivity: Effect of corticotropin releasing factor receptors assessed by spinal neurophysiology and neurochemistry. [PDF]

Neuropharmacology, 2023
Robbins MT, DeWitte C, Ness TJ.
europepmc   +1 more source

Melatonin as a protector against endocrine disruption across tissues: A systematic review

Physiological Reports, Volume 14, Issue 15, August 2026.
Graphical Abstract showing the biological mechanisms by which melatonin protects tissues against endocrine disruption. Abstract Endocrine‐disrupting chemicals (EDCs) are widespread environmental pollutants that interfere with hormonal homeostasis and contribute to multisystem toxicity.
Clenie Isingizwe, Gaudence Ndinganire, Abdullateef Isiaka Alagbonsi   +2 more
wiley   +1 more source

The Psychedelic Psilocin Suppresses Activity of Central Amygdala Corticotropin-Releasing Factor Receptor 1 Neurons and Decreases Ethanol Drinking in Female Mice. [PDF]

J Neurosci
Magee SN, Sereno AC, Echeveste-Sanchez M, Shannon EG, Mohsin A, Mott SE, Faccidomo SP, Hodge CW, Herman MA.   +8 more
europepmc   +1 more source

Intermittent Fasting Exerts Antidepressant‐Like Effects by Restoring HPA Axis Homeostasis Through Coordinated GR–MR Signaling

The FASEB Journal, Volume 40, Issue 13, 15 July 2026.
Intermittent fasting (IF) exerts antidepressant‐like effects by restoring impaired cooperative signaling between glucocorticoid receptor (GR) and mineralocorticoid receptor (MR), thereby modulating hypothalamic neurocircuit activity and reinstating HPA axis homeostasis.
Miaomiao Tang, Qihan Sun, Jinfang Song, Xinmiao Piao, Zihui Geng, Xu Han, Runxin Li, Yue Li, Mengyi Han, Ranji Cui, Bingjin Li   +10 more
wiley   +1 more source

Corticotropin-releasing factor type 1 receptors in the rat nodose ganglion are involved in the transduction of stress-induced visceral sensory signals to the brain. [PDF]

J Neuroendocrinol
Mano-Otagiri A, Shibasaki T, Sakai A, Kakinuma Y.   +3 more
europepmc   +1 more source

Corticotropin releasing factor-1 receptor antagonism associated with favorable outcomes of male reproductive health biochemical parameters. [PDF]

Front Endocrinol (Lausanne), 2023
Khattab A, Charlton RW.
europepmc   +1 more source